Skip to main content
. 2017 Oct 23;297(1):153–159. doi: 10.1007/s00404-017-4563-x

Table 4.

Correlation of MMR gene expression level with overall survival in ovarian cancer patients with different TP53 mutation status

MMR genes TP53 mutation Cases HR 95% CI P value
MSH2 Yes 402 1.13 0.86–1.47 0.39
No 82 0.75 0.41–1.37 0.35
MSH3 Yes 402 1.01 0.78–1.32 0.93
No 82 1.13 0.62–2.06 0.7
MSH6 Yes 402 0.78 0.59–1.01 0.063
No 82 1.73 0.85–3.52 0.13
MLH1 Yes 402 0.86 0.65–1.14 0.3
No 82 1.54 0.85–2.79 0.15
MLH3 Yes 402 0.87 0.67–1.14 0.31
No 82 1.22 0.68–2.21 0.51
PMS1 Yes 402 0.9 0.69–1.18 0.44
No 82 0.91 0.5–1.63 0.74
PMS2 Yes 402 0.82 0.63–1.08 0.15
No 82 2.15 1.06–4.36 0.03*

*P < 0.05